AKER BIOMARINE 28 March 2023 : The annual general meeting ofAker BioMarine ASA will be held on Thursday20 April 2023 at15:00 CET . The meeting will be conducted as a virtual meeting only, and voting will be handled online during the meeting. Information about log-in details for the meeting is available in the notice of the general meeting. For further information regarding participation, please go to www.akerbiomarine/agm. No pre-registration is needed for attending online, but attendees must be logged in before the meeting starts. Deadline for registration of advance votes and proxies is19 April 2023 at16:00 CET . Please find attached the following documents: - Notice and proxy forms for the Annual General Meeting 2023 - Proposal from the Nomination Committee All documents to be processed in the meeting are available on www.akerbiomarine/agm. For further information, please contactKatrine Klaveness , CFO Mobile: +47 991 58 915 Email: Katrine.Klaveness@akerbiomarine.com This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act. AboutAker BioMarine Aker BioMarine is a leading biotech innovator and Antarctic krill-harvesting company developing krill-derived products for pharma, consumer health and wellness as well as animal nutrition. The company has a strong position in its industry and is the world's leading supplier of krill, the natural, powerful and health promoting source of nutrients from the pristine waters ofAntarctica .Aker BioMarine is listed onOslo Stock Exchange (AKBM). More information is available at www.akerbiomarine.com.
Click here for more information
© Oslo Bors ASA, source
